Form DEF 14A Minerva Neurosciences Inc For: 23 April
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Minerva Neurosciences Inc (NERV)
The Minerva Neurosciences share price today is 6.070, view NASDAQ NERV stock exchange data. Track the latest Minerva Neurosciences share price with real-time updates on NERV stock performance including market cap, day range, 52-week range and dividend yield. Access NERV charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.050
6.500
52 wk Range
1.300
12.460
Earnings results expected in 3 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.0506.500
52 wk Range
1.30012.460
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NERV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
9.500
Upside
+56.51%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Form 8K Minerva Neurosciences Inc For: 6 April
- Investing.com
- Minerva Neu receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Form DEF 14A Minerva Neurosciences Inc For: 23 April
- Investing.com
- Minerva Neu receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form PRE 14A Minerva Neurosciences Inc For: 10 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 9.500
(+56.51% Upside)
Earnings
Latest Release
11-03-2026
EPS / Forecast
-0.64 / -0.11
Revenue / Forecast
-- / --
Compare NERV to Peers and Sector
Metrics to compare | NERV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNERVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.9x | −7.2x | −0.5x | |
PEG Ratio | 0.00 | −0.09 | 0.00 | |
Price/Book | −1.9x | 5.1x | 2.6x | |
Price / LTM Sales | - | 106.9x | 3.2x | |
Upside (Analyst Target) | 23.6% | 67.3% | 48.1% | |
Fair Value Upside | Unlock | −6.6% | 6.6% | Unlock |
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Minerva Neurosciences (NERV) Share Price Today?
The Minerva Neurosciences share price today is 6.070.
What is the current Minerva Neurosciences (NERV) share price and day range?
As of 03-05-2026, the Minerva Neurosciences share price is 6.070, with a previous close of 6.470. The share price has ranged from 6.050 to 6.500 today, while the 52-week range spans from 1.300 to 12.460.
What Is the Minerva Neurosciences Market Cap?
As of today, Minerva Neurosciences market cap is 266.120M.
What Is the Minerva Neurosciences (NERV) Share Price Target?
The average 12-month share price target for Minerva Neurosciences is 9.500, with a high estimate of 14 and a low estimate of 7. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Neutral and +56.51% Upside potential.
What Is Minerva Neurosciences's Earnings Per Share (TTM)?
The Minerva Neurosciences EPS (TTM) is -34.670.
When Is the Next Minerva Neurosciences Earnings Date?
Minerva Neurosciences will release its next earnings report on 06-05-2026.
From a Technical Analysis Perspective, Is NERV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Minerva Neurosciences Trade On?
Minerva Neurosciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Minerva Neurosciences?
The stock symbol for Minerva Neurosciences is "NERV."
How Many Times Has Minerva Neurosciences Stock Split?
Minerva Neurosciences has split 1 times.
How Many Employees Does Minerva Neurosciences Have?
Minerva Neurosciences has 7 employees.
What Is the NERV Premarket Price?
NERV's last pre-market stock price is 6.500. The pre-market share volume is 11.000, and the stock has changed by 0.030, or 0.460%.
What Is the NERV After Hours Price?
NERV's last after hours stock price is 6.000, the stock has changed by -0.070, or -1.150%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.